{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:28:27Z","timestamp":1792639707796,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006641","name":"Cure Brain Cancer Foundation","doi-asserted-by":"publisher","award":["CBL0137"],"award-info":[{"award-number":["CBL0137"]}],"id":[{"id":"10.13039\/501100006641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008221","name":"Cure Starts Now Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.celrep.2021.108994","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T10:30:33Z","timestamp":1618482633000},"page":"108994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG"],"prefix":"10.1016","volume":"35","author":[{"given":"Anahid","family":"Ehteda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Franshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-9908","authenticated-orcid":false,"given":"Federico M.","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-6515","authenticated-orcid":false,"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6206-9463","authenticated-orcid":false,"given":"Jourdin R.C.","family":"Rouaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Nam Ignatius","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Pandher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6398-3046","authenticated-orcid":false,"given":"Chelsea","family":"Mayoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaminah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Tolhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kankean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-5971","authenticated-orcid":false,"given":"Rebecca","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Trebilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Gurova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei V.","family":"Gudkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-4589","authenticated-orcid":false,"given":"Murray D.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-8817","authenticated-orcid":false,"given":"Michelle","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Vittorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7451-7916","authenticated-orcid":false,"given":"David S.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2021.108994_bib1","doi-asserted-by":"crossref","first-page":"7784","DOI":"10.1073\/pnas.1305859110","article-title":"Accumulation of the FACT complex, as well as histone H3.3, serves as a target marker for somatic hypermutation","volume":"110","author":"Aida","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.108994_bib2","doi-asserted-by":"crossref","first-page":"dev162693","DOI":"10.1242\/dev.162693","article-title":"The developmental origin of brain tumours: A cellular and molecular framework","volume":"145","author":"Azzarelli","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.celrep.2021.108994_bib3","first-page":"186","article-title":"Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma","volume":"19","author":"Barone","year":"2017","journal-title":"Neuro-oncol."},{"key":"10.1016\/j.celrep.2021.108994_bib4","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2021.108994_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.108994_bib6","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1038\/sj.onc.1210516","article-title":"p21Waf1\/Cip1\/Sdi1 mediates retinoblastoma protein degradation","volume":"26","author":"Broude","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2021.108994_bib7","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1021\/ja5060934","article-title":"Strategy for \u201cdetoxification\u201d of a cancer-derived histone mutant based on mapping its interaction with the methyltransferase PRC2","volume":"136","author":"Brown","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.celrep.2021.108994_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nsmb.2461","article-title":"Histone chaperones in nucleosome assembly and human disease","volume":"20","author":"Burgess","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2021.108994_bib9","doi-asserted-by":"crossref","first-page":"11038","DOI":"10.18632\/oncotarget.2701","article-title":"Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer","volume":"5","author":"Burkhart","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2021.108994_bib10","doi-asserted-by":"crossref","first-page":"312ra176","DOI":"10.1126\/scitranslmed.aab1803","article-title":"Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma","volume":"7","author":"Carter","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2021.108994_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1101\/gad.217778.113","article-title":"The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression","volume":"27","author":"Chan","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2021.108994_bib12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ncb2116","article-title":"Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2","volume":"12","author":"Chen","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2021.108994_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.molcel.2018.06.020","article-title":"Functions of FACT in breaking the nucleosome and maintaining its integrity at the single-nucleosome level","volume":"71","author":"Chen","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2021.108994_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: An International Diffuse Intrinsic Pontine Glioma Registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro-oncol."},{"issue":"Suppl 2","key":"10.1016\/j.celrep.2021.108994_bib15","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/neuonc\/noy059.115","article-title":"DIPG-22. A phase 1 trial of the histone deacetylase inhibitor panobinostat in pediatric patients with recurrent or refractory diffuse intrinsic pontine glioma: A Pediatric Brain Tumor Consortium (PBTC) study","volume":"20","author":"Cooney","year":"2018","journal-title":"Neuro-oncol."},{"key":"10.1016\/j.celrep.2021.108994_bib16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","article-title":"Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG","volume":"15","author":"Cordero","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.celrep.2021.108994_bib17","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1158\/1535-7163.MCT-14-0013","article-title":"Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-\u03baB, and cell-cycle progression in non-small cell lung cancer","volume":"13","author":"Dermawan","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2021.108994_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2014.06.003","article-title":"The genetic signatures of pediatric high-grade glioma: No longer a one-act play","volume":"24","author":"Diaz","year":"2014","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.celrep.2021.108994_bib19","doi-asserted-by":"crossref","first-page":"e1800479","DOI":"10.1002\/pmic.201800479","article-title":"Signal transduction in diffuse intrinsic pontine glioma","volume":"19","author":"Duchatel","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.celrep.2021.108994_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: From biological insights to therapeutic potential","volume":"6","author":"Gan","year":"2018","journal-title":"Biomark. Res."},{"key":"10.1016\/j.celrep.2021.108994_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.18632\/oncotarget.340","article-title":"Expression of FACT in mammalian tissues suggests its role in maintaining of undifferentiated state of cells","volume":"2","author":"Garcia","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2021.108994_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.celrep.2013.06.013","article-title":"Facilitates chromatin transcription complex is an \u201caccelerator\u201d of tumor transformation and potential marker and target of aggressive cancers","volume":"4","author":"Garcia","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2021.108994_bib23","doi-asserted-by":"crossref","first-page":"95ra74","DOI":"10.1126\/scitranslmed.3002530","article-title":"Curaxins: Anticancer compounds that simultaneously suppress NF-\u03baB and activate p53 by targeting FACT","volume":"3","author":"Gasparian","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2021.108994_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0715-827a","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.108994_bib55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pbc.24060","article-title":"Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma","volume":"58","author":"Grill","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.celrep.2021.108994_bib25","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1101\/gad.813200","article-title":"The Rb\/E2F pathway: Expanding roles and emerging paradigms","volume":"14","author":"Harbour","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2021.108994_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2176\/nmc.ra.2017-0018","article-title":"Epigenetic targeted therapy for diffuse intrinsic pontine glioma","volume":"57","author":"Hashizume","year":"2017","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.celrep.2021.108994_bib27","doi-asserted-by":"crossref","first-page":"e0169485","DOI":"10.1371\/journal.pone.0169485","article-title":"Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models","volume":"12","author":"Hennika","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2021.108994_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1570159X14666160509123229","article-title":"Diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets","volume":"15","author":"Johung","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.celrep.2021.108994_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1158\/1940-6207.CAPR-11-0529","article-title":"Targeting FACT complex suppresses mammary tumorigenesis in Her2\/neu transgenic mice","volume":"5","author":"Koman","year":"2012","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.celrep.2021.108994_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.108994_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.108994_bib32","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1523\/JNEUROSCI.2840-13.2014","article-title":"E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation","volume":"34","author":"Magri","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2021.108994_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ceb.2006.02.006","article-title":"MCM proteins and DNA replication","volume":"18","author":"Maiorano","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.celrep.2021.108994_bib34","doi-asserted-by":"crossref","first-page":"E8246","DOI":"10.1073\/pnas.1802620115","article-title":"Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8","volume":"115","author":"Marie","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.108994_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.108994_bib36","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1093\/nar\/gkz433","article-title":"A new normalization for Nanostring nCounter gene expression data","volume":"47","author":"Molania","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2021.108994_bib37","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.108994_bib38","doi-asserted-by":"crossref","first-page":"e201800085","DOI":"10.26508\/lsa.201800085","article-title":"Transcriptional repression by FACT is linked to regulation of chromatin accessibility at the promoter of ES cells","volume":"1","author":"Mylonas","year":"2018","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.celrep.2021.108994_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic pontine glioma","volume":"31","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.108994_bib40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/hmg\/10.7.699","article-title":"The Rb\/E2F pathway and cancer","volume":"10","author":"Nevins","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2021.108994_bib41","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.4161\/cc.8.23.10179","article-title":"Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications","volume":"8","author":"Neznanov","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.celrep.2021.108994_bib42","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","article-title":"Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma","volume":"29","author":"Paugh","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2021.108994_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.108994_bib44","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ijc.26158","article-title":"Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity","volume":"130","author":"Preet","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.celrep.2021.108994_bib45","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2021.108994_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/pr.2013.194","article-title":"Children are not just little adults: Recent advances in understanding of diffuse intrinsic pontine glioma biology","volume":"75","author":"Schroeder","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.celrep.2021.108994_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.108994_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.108994_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/cells6030026","article-title":"The potential of targeting brain pathology with Ascl1\/Mash1","volume":"6","author":"Tang","year":"2017","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2021.108994_bib50","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.18632\/oncotarget.24045","article-title":"Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma","volume":"9","author":"Tsoli","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2021.108994_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fonc.2015.00237","article-title":"DIPG in Children - What Can We Learn from the Past?","volume":"5","author":"Vanan","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.celrep.2021.108994_bib51","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.108994_bib52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bpa.12042","article-title":"Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas","volume":"23","author":"Venneti","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.celrep.2021.108994_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2021.108994_bib54","doi-asserted-by":"crossref","first-page":"12141","DOI":"10.18632\/oncotarget.3716","article-title":"The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma","volume":"6","author":"Yadavilli","year":"2015","journal-title":"Oncotarget"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721003089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721003089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:17:50Z","timestamp":1761909470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124721003089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2211124721003089"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2021.108994","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2021.108994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"108994"}}